Stemline Therapeutics Inc

Street Watch: Top Analysts Make Moves on 3 Buy-Rated Stocks

Onward and upward the market goes, with December providing further cheer as new record highs for the S&P 500 were notched in the …

Marty Shtrubel — December 26, 2019, 10:04 AM EDT

Cowen Puts Stemline Therapeutics Inc’s (STML) Stock Collapse Into Perspective

Stemline Therapeutics Inc (NASDAQ:STML) was mentioned cautiously in an article by Adam Feuerstein of TheStreet. According to to the report, a patient died …

Jason Cohen — February 2, 2017, 3:53 PM EDT

Roth Capital Reiterates Buy On Stemline Following 3Q14 Results

Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Stemline Therapeutics Inc (NASDAQ:STML) with a price target of $62, which represents a …

Ben Mahaney, Editor — November 14, 2014, 9:59 AM EDT

Stemline Is Poised For A Significant Increase In Visibility, Says Roth Capital

In a research report issued Monday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Stemline Therapeutics (NASDAQ:STML) with a price target …

Corey Williams — October 27, 2014, 1:32 PM EDT

Roth Capital Reiterates Buy On Stemline Therapeutics, $62 PT

In a research report issued today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Stemline Therapeutics Inc (NASDAQ:STML) with a price …

Corey Williams — October 16, 2014, 3:52 PM EDT